Table 2.
Response to treatment
Sertraline | Placebo | P | |
---|---|---|---|
A1C levels (%) | |||
Baseline | 10.0 ± 1.8 | 9.7 ± 1.6 | NS |
6 months | 8.0 ± 1.4 | 8.8 ± 1.9 | <0.01 |
P | <0.001 | <0.01 | |
Systolic blood pressure (mmHg) | |||
Baseline | 137 ± 13 | 137 ± 14 | NS |
6 months | 122 ± 15 | 131 ± 14 | =0.003 |
P | <10−5 | =0.01 | |
Diastolic blood pressure (mmHg) | |||
Baseline | 73 ± 9 | 75 ± 12 | NS |
6 months | 72 ± 10 | 72 ± 11 | NS |
P | NS | NS | |
LDL cholesterol concentration (mg/dl) | |||
Baseline | 101 ± 29 | 99 ± 34 | NS |
6 months | 91 ± 28 | 93 ± 30 | NS |
P | NS | NS | |
Weight (lbs) | |||
Baseline | 181.6 ± 40.0 | 188.1 ± 61.7† | NS |
6 months | 181.5 ± 40.2 | 188.7 ± 58.8† | NS |
P | NS | NS | |
HAM-D scores* | |||
Baseline | 19 ± 5 | 20 ± 6 | NS |
6 months | 11 ± 6 | 13 ± 8 | NS |
P | <0.001 | <0.001 | |
Pain scale | |||
Baseline | 6 ± 2 | 6 ± 2 | NS |
6 months | 4 ± 3 | 4 ± 3 | NS |
P | <0.001 | =0.01 |
Data are means ± SD.
*Depression score: 0–7, none; 8–13, mild; 14–18, moderate; 19–22, severe; >22, very severe.
†n = 43 (one patient in wheelchair and weight not measured). NS, nonsignificant (P > 0.05).